Company news: InTouch Solutions, MedCityNews and Lippincott

Share this article:
Healthcare agency and platform developer InTouch Solutions partnered with marketing firm MD Mindset to deliver a joint set of services. Wendy Blackburn, InTouch EVP, told MM&M the collaboration is still in its defining stages, but that the relationship will allow the two companies to offer their complementary skill sets to clients in tandem, or to introduce each other's capabilities as client needs arise. Services on tap include InTouch's Allora platform, which the agency uses to build apps, and MD Mindset's usage metrics that can be used to assess what makes a tablet presentation effective on sales calls. “You can't take it for granted that people are building iPad apps the right's far too easy to take a viz aide and throw a PDF onto an iPad," she said. "It is a lot less about what the pharma company wants to provide in terms of's much more about what the doctor wants to see, and that's where we can really make a difference.”

Content Marketing Institute and are holding their first Content Marketing World Summit in November. The two-day meeting will be held in Cleveland, OH, and will focus on healthcare marketing, including professionals from the Mayo Clinic, Johns Hopkins Medicine and the Cleveland Clinic. Topics will include social media and content creation for hospitals, content marketing metrics and ROI and managing the content marketing process. It will be held November 7 to November 8.

The Crohn's and Colitis Foundation has named Lippincott Williams & Wilkins publisher of Inflammatory Bowel Disease. Lippincott is a division of Wolters Kluwer Health. The online journal is currently available to 12,000 institutions through Wolters Kluwer's research platform OvidSP.
Share this article:

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.